Mark E. Bunnage

5.3k total citations · 1 hit paper
51 papers, 2.9k citations indexed

About

Mark E. Bunnage is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Mark E. Bunnage has authored 51 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 25 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Mark E. Bunnage's work include Synthetic Organic Chemistry Methods (13 papers), Asymmetric Synthesis and Catalysis (8 papers) and Protein Degradation and Inhibitors (7 papers). Mark E. Bunnage is often cited by papers focused on Synthetic Organic Chemistry Methods (13 papers), Asymmetric Synthesis and Catalysis (8 papers) and Protein Degradation and Inhibitors (7 papers). Mark E. Bunnage collaborates with scholars based in United Kingdom, United States and Switzerland. Mark E. Bunnage's co-authors include Lyn H. Jones, Stephen G. Davies, Christopher J. Goodwin, Eugene L. Piatnitski Chekler, K. C. Nicolaou, Kazunori Koide, Stefan Knapp, P. Filippakopoulos, S. Picaud and Martin Philpott and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Nature Reviews Drug Discovery.

In The Last Decade

Mark E. Bunnage

50 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

2023 98 citations Mark E. Bunnage et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark E. Bunnage United Kingdom	30	1.7k	1.3k	309	300	254	51	2.9k
Scott A. Biller United States	27	1.5k 0.9×	830 0.7×	142 0.5×	159 0.5×	262 1.0×	53	2.8k
Paul V. Fish United Kingdom	22	1.9k 1.1×	648 0.5×	321 1.0×	286 1.0×	324 1.3×	59	3.0k
Carl P. Decicco United States	33	1.3k 0.8×	1.2k 1.0×	169 0.5×	203 0.7×	772 3.0×	100	3.4k
Julian Blagg United Kingdom	30	1.8k 1.0×	1.2k 0.9×	170 0.6×	714 2.4×	567 2.2×	94	3.5k
Takayoshi Kinoshita Japan	32	1.5k 0.9×	1.0k 0.8×	86 0.3×	273 0.9×	461 1.8×	142	3.0k
Lawrence G. Hamann United States	32	1.8k 1.0×	1.3k 1.0×	119 0.4×	121 0.4×	498 2.0×	64	4.2k
Patrick A. Marcotte United States	33	1.5k 0.9×	784 0.6×	141 0.5×	182 0.6×	529 2.1×	67	2.6k
Joseph M. Salvino United States	34	2.3k 1.3×	1.2k 1.0×	153 0.5×	204 0.7×	691 2.7×	106	3.7k
Paul A. Sprengeler United States	32	1.9k 1.1×	1.8k 1.5×	466 1.5×	191 0.6×	449 1.8×	82	3.6k
Steven K. Davidsen United States	31	1.9k 1.1×	1000 0.8×	209 0.7×	178 0.6×	702 2.8×	80	3.0k

Countries citing papers authored by Mark E. Bunnage

Since Specialization

Citations

This map shows the geographic impact of Mark E. Bunnage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Bunnage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Bunnage more than expected).

Fields of papers citing papers by Mark E. Bunnage

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Bunnage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Bunnage. The network helps show where Mark E. Bunnage may publish in the future.

Co-authorship network of co-authors of Mark E. Bunnage

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Bunnage. A scholar is included among the top collaborators of Mark E. Bunnage based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Bunnage. Mark E. Bunnage is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Bu, Brian Juba, Michael L. Vazquez, et al.. (2017). Microfluidic-Enabled Intracellular Delivery of Membrane Impermeable Inhibitors to Study Target Engagement in Human Primary Cells. ACS Chemical Biology. 12(12). 2970–2974. 24 indexed citations

Jones, Lyn H. & Mark E. Bunnage. (2017). Applications of chemogenomic library screening in drug discovery. Nature Reviews Drug Discovery. 16(4). 285–296. 119 indexed citations

Li, Xing, David C. Blakemore, Arjun Narayanan, et al.. (2015). Fluorine in Drug Design: A Case Study with Fluoroanisoles. ChemMedChem. 10(4). 715–726. 122 indexed citations

Bunnage, Mark E., A. Gilbert, Lyn H. Jones, & Erik C. Hett. (2015). Know your target, know your molecule. Nature Chemical Biology. 11(6). 368–372. 72 indexed citations

Bunnage, Mark E., Eugene L. Piatnitski Chekler, & Lyn H. Jones. (2013). Target validation using chemical probes. Nature Chemical Biology. 9(4). 195–199. 289 indexed citations

Farrant, Elizabeth, et al.. (2011). Lead diversification. Application to existing drug molecules: Mifepristone 1 and antalarmin 8. Bioorganic & Medicinal Chemistry Letters. 22(1). 723–728. 15 indexed citations

Roberts, Lee R., Paul A. Bradley, Mark E. Bunnage, et al.. (2011). Acidic triazoles as soluble guanylate cyclase stimulators. Bioorganic & Medicinal Chemistry Letters. 21(21). 6515–6518. 22 indexed citations

Bunnage, Mark E., Andrew Calabrese, Elizabeth Farrant, et al.. (2011). Lead Diversification 2: Application to P38, gMTP and lead compounds. Bioorganic & Medicinal Chemistry Letters. 22(2). 1255–1262. 13 indexed citations

Bunnage, Mark E.. (2011). Getting pharmaceutical R&D back on target. Nature Chemical Biology. 7(6). 335–339. 191 indexed citations

10.

Owen, Dafydd R., et al.. (2009). Oxygenated analogues of UK-396082 as inhibitors of activated thrombin activatable fibrinolysis inhibitor. Bioorganic & Medicinal Chemistry Letters. 20(1). 92–96. 10 indexed citations

11.

Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2008). The discovery of adamantyl-derived, inhaled, long acting β2-adrenoreceptor agonists. Bioorganic & Medicinal Chemistry Letters. 18(4). 1280–1283. 28 indexed citations

12.

Bunnage, Mark E., John P. Mathias, Anthony Wood, Duncan C. Miller, & S. D. A. STREET. (2008). Highly potent and selective chiral inhibitors of PDE5: An illustration of Pfeiffer’s rule. Bioorganic & Medicinal Chemistry Letters. 18(23). 6033–6036. 3 indexed citations

13.

Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2007). The discovery of long acting β2-adrenoreceptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(14). 4012–4015. 29 indexed citations

14.

Brown, Alan D., Mark E. Bunnage, Paul A. Glossop, et al.. (2007). The discovery of indole-derived long acting β2-adrenoceptor agonists for the treatment of asthma and COPD. Bioorganic & Medicinal Chemistry Letters. 17(22). 6188–6191. 22 indexed citations

15.

Bunnage, Mark E., Stephen G. Davies, Paul M. Roberts, Andrew D. Smith, & Jonathan M. Withey. (2004). Asymmetric synthesis of the cis- and trans-stereoisomers of 4-aminopyrrolidine-3-carboxylic acid and 4-aminotetrahydrofuran-3-carboxylic acid. Organic & Biomolecular Chemistry. 2(19). 2763–2763. 32 indexed citations

16.

Bunnage, Mark E., et al.. (2003). Asymmetric synthesis of (1R,2S,3R)-3-methylcispentacin and (1S,2S,3R)-3-methyltranspentacin by kinetic resolution of tert-butyl (±)-3-methylcyclopentene-1-carboxylate. Organic & Biomolecular Chemistry. 1(21). 3698–3707. 26 indexed citations

17.

Nicolaou, K. C., Guoqiang Shi, Janet L. Gunzner, et al.. (1999). Total Synthesis of Brevetoxin A: Part 3: Construction of GHIJ and BCDE Ring Systems. Chemistry - A European Journal. 5(2). 628–645. 43 indexed citations

18.

Bunnage, Mark E. & K. C. Nicolaou. (1997). The Oxide Anion Accelerated Retro‐Diels‐Alder Reaction. Chemistry - A European Journal. 3(2). 187–192. 23 indexed citations

19.

Bunnage, Mark E. & K. C. Nicolaou. (1996). Endiine durch Retro‐Diels‐Alder‐Reaktion. Angewandte Chemie. 108(10). 1178–1180. 3 indexed citations

20.

Koide, Kazunori, Mark E. Bunnage, Luigi Gomez Paloma, et al.. (1995). Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol. Chemistry & Biology. 2(9). 601–608. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact